LKQ Corporation

Fundamentals7.0
Price Action6.0
News Sentiment6.0
AI Rating
6.0

Key Drivers

  • Strong FCF
  • High leverage
  • Qtr margin compression

AI
AI Summary

6.0

LKQ is now more a capital‑allocation/deleveraging story than a pure operations rebound: its sizable FCF and credible asset‑sale optionality can materially reprice the stock if proceeds are explicitly used to pay down the 2026 term loan and fund targeted margin restoration, but the outcome is binary—successful deleveraging versus refinancing/execution failure. Monitor near‑term evidence of asset‑sale proceeds applied to debt and sequential EBITDA/margin improvement in Europe and wholesale as the key catalysts.

CapitalAllocation
RefinancingRisk
ExecutionWatch‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Strong FCF
  • High leverage
  • Qtr margin compression

LKQ combines strong scale and annual cash generation (FCF $847M) and solid gross margins with a meaningful dividend yield, but high leverage, large intangibles and recent quarterly margin compression pose near-term risks despite modest valuation multiples.

StableCash
MarginRisk

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Below last-month SMA
  • Testing cluster support
  • Continued selling pressure

LKQ is in a short-term downtrend with price below its last-month SMA (~$30.98), down ~16% over the month and testing support in the $28.20–$28.80 zone.

Bearish
Support Level: $28.20–$28.80
Resistance Level: $32.50–$34.00

Price fell from $33.77 on 2026-02-20 to $28.26 on 2026-03-20 (~16% drop), with a further short-run drop from $29.75 to $28.26 (~5%)

Sentiment & News

6.0

Key News Insights:

  • Earnings plunge
  • Activist stake
  • Potential divestiture

LKQ faces pronounced operational and earnings weakness (50% y/y EPS drop) with mixed institutional moves and an activist stake, while a potential Specialty-segment sale is the main catalyst that could stabilize valuation.

SpecialtySale

Continued operational pressure will likely keep the stock underperforming unless management pursues a clear strategic action (e.g., Specialty sale) that materially improves growth or valuation